BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27366092)

  • 1. miR-135a acts as a tumor suppressor in gastric cancer in part by targeting KIFC1.
    Zhang C; Chen X; Chen X; Wang X; Ji A; Jiang L; Sang F; Li F
    Onco Targets Ther; 2016; 9():3555-63. PubMed ID: 27366092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-635 targets KIFC1 to inhibit the progression of gastric cancer.
    Cao FY; Zheng YB; Yang C; Huang SY; He XB; Tong SL
    J Investig Med; 2020 Dec; 68(8):1357-1363. PubMed ID: 32753405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-135a and Promotes JAK2/STAT3 Signal Pathway in Gastric Cancer.
    Wang X; Kan J; Han J; Zhang W; Bai L; Wu H
    J Cancer; 2019; 10(4):1013-1022. PubMed ID: 30854107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-κB activation.
    Xie Y; Li F; Li Z; Shi Z
    Onco Targets Ther; 2019; 12():975-984. PubMed ID: 30774383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
    Wu H; Huang M; Cao P; Wang T; Shu Y; Liu P
    Cancer Biol Ther; 2012 Mar; 13(5):281-8. PubMed ID: 22310976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1.
    Zeng YB; Liang XH; Zhang GX; Jiang N; Zhang T; Huang JY; Zhang L; Zeng XC
    Cancer Cell Int; 2016; 16():63. PubMed ID: 27486383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-135a acts as a tumor suppressor by targeting ASPH in endometrial cancer.
    Chen X; Jin P; Tang H; Zhang L
    Int J Clin Exp Pathol; 2019; 12(9):3384-3389. PubMed ID: 31934181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
    Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.
    Liu Y; Zhan P; Zhou Z; Xing Z; Zhu S; Ma C; Li Q; Zhu Q; Miao Y; Zhang J; Lv T; Song Y
    J Thorac Dis; 2016 Oct; 8(10):2911-2923. PubMed ID: 27867568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-3940-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28.
    Ren K; Li Y; Lu H; Li Z; Han X
    Transl Oncol; 2017 Feb; 10(1):80-89. PubMed ID: 27988424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
    Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
    Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
    Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of KIFC1 expression in gastric cancer spheroids.
    Oue N; Mukai S; Imai T; Pham TT; Oshima T; Sentani K; Sakamoto N; Yoshida K; Yasui W
    Oncol Rep; 2016 Jul; 36(1):349-55. PubMed ID: 27176706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.
    Zhang Y; Jiang WL; Yang JY; Huang J; Kang G; Hu HB; Xie S
    J Cell Physiol; 2019 Aug; 234(10):18679-18687. PubMed ID: 30993701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
    Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
    Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of CircRNA_0001946 Contributes to the Proliferation and Metastasis of Colorectal Cancer Cells by Targeting MicroRNA-135a-5p.
    Deng Z; Li X; Wang H; Geng Y; Cai Y; Tang Y; Wang Y; Yu X; Li L; Li R
    Front Genet; 2020; 11():357. PubMed ID: 32508871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.